311 related articles for article (PubMed ID: 26173433)
21. Licochalcone A inhibits cell growth through the downregulation of the Hippo pathway via PES1 in cholangiocarcinoma cells.
Xu KD; Miao Y; Li P; Li PP; Liu J; Li J; Cao F
Environ Toxicol; 2022 Mar; 37(3):564-573. PubMed ID: 34845814
[TBL] [Abstract][Full Text] [Related]
22. Cordycepin Inhibits Cancer Cell Proliferation and Angiogenesis through a DEK Interaction via ERK Signaling in Cholangiocarcinoma.
Liu T; Zhu G; Yan W; Lv Y; Wang X; Jin G; Cui M; Lin Z; Ren X
J Pharmacol Exp Ther; 2020 May; 373(2):279-289. PubMed ID: 32102917
[TBL] [Abstract][Full Text] [Related]
23. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the Hippo Pathway Transcription Factor TEAD.
Lin KC; Park HW; Guan KL
Trends Biochem Sci; 2017 Nov; 42(11):862-872. PubMed ID: 28964625
[TBL] [Abstract][Full Text] [Related]
25. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
[TBL] [Abstract][Full Text] [Related]
26. Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma.
Yokota K; Serada S; Tsujii S; Toya K; Takahashi T; Matsunaga T; Fujimoto M; Uemura S; Namikawa T; Murakami I; Kobayashi S; Eguchi H; Doki Y; Hanazaki K; Naka T
Mol Cancer Ther; 2021 Sep; 20(9):1713-1722. PubMed ID: 34224365
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
[TBL] [Abstract][Full Text] [Related]
28. Yap/Taz-TEAD activity links mechanical cues to progenitor cell behavior during zebrafish hindbrain segmentation.
Voltes A; Hevia CF; Engel-Pizcueta C; Dingare C; Calzolari S; Terriente J; Norden C; Lecaudey V; Pujades C
Development; 2019 Jul; 146(14):. PubMed ID: 31273051
[TBL] [Abstract][Full Text] [Related]
29. Identification of mechanism that couples multisite phosphorylation of Yes-associated protein (YAP) with transcriptional coactivation and regulation of apoptosis.
Lee KK; Yonehara S
J Biol Chem; 2012 Mar; 287(12):9568-78. PubMed ID: 22308035
[TBL] [Abstract][Full Text] [Related]
30. The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma.
Buckarma EH; Werneburg NW; Conboy CB; Kabashima A; O'Brien DR; Wang C; Ilyas SI; Smoot RL
Mol Cancer Res; 2020 Oct; 18(10):1574-1588. PubMed ID: 32646966
[TBL] [Abstract][Full Text] [Related]
31. Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy.
Bokhovchuk F; Mesrouze Y; Izaac A; Meyerhofer M; Zimmermann C; Fontana P; Schmelzle T; Erdmann D; Furet P; Kallen J; Chène P
FEBS J; 2019 Jun; 286(12):2381-2398. PubMed ID: 30903741
[TBL] [Abstract][Full Text] [Related]
32. SAHA induce hippo pathway in CCA cells without increasing cell proliferation.
Özel M; Başkol G; Başkol M; Güneş F; Uçar Ç; Doğru BN; Akalın H
Mol Biol Rep; 2022 May; 49(5):3649-3656. PubMed ID: 35112301
[TBL] [Abstract][Full Text] [Related]
33. Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.
Yang SH; Lin HY; Chang VH; Chen CC; Liu YR; Wang J; Zhang K; Jiang X; Yen Y
Oncotarget; 2015 Sep; 6(27):23857-73. PubMed ID: 26160843
[TBL] [Abstract][Full Text] [Related]
34. Loss of liver-intestine cadherin in human intrahepatic cholangiocarcinoma promotes angiogenesis by up-regulating metal-responsive transcription factor-1 and placental growth factor.
Takamura M; Yamagiwa S; Wakai T; Tamura Y; Kamimura H; Kato T; Tsuchiya A; Matsuda Y; Shirai Y; Ichida T; Ajioka Y; Aoyagi Y
Int J Oncol; 2010 Jan; 36(1):245-54. PubMed ID: 19956853
[TBL] [Abstract][Full Text] [Related]
35. Homeobox A4 suppresses vascular remodeling by repressing YAP/TEAD transcriptional activity.
Kimura M; Horie T; Baba O; Ide Y; Tsuji S; Ruiz Rodriguez R; Watanabe T; Yamasaki T; Otani C; Xu S; Miyasaka Y; Nakashima Y; Kimura T; Ono K
EMBO Rep; 2020 Apr; 21(4):e48389. PubMed ID: 32147946
[TBL] [Abstract][Full Text] [Related]
36. The regulation and function of YAP transcription co-activator.
Zhu C; Li L; Zhao B
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
[TBL] [Abstract][Full Text] [Related]
37. An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma.
Marzioni M; Torrice A; Saccomanno S; Rychlicki C; Agostinelli L; Pierantonelli I; Rhönnstad P; Trozzi L; Apelqvist T; Gentile R; Candelaresi C; Fava G; Semeraro R; Benedetti A; Gaudio E; Franchitto A; Onori P; De Minicis S; Carpino G; Kallin E; Alvaro D; Nilsson S
Dig Liver Dis; 2012 Feb; 44(2):134-42. PubMed ID: 21782536
[TBL] [Abstract][Full Text] [Related]
38. Role of the embryonic protein SOX2 in cholangiocarcinoma.
Sun Q; Li J; Wang G; Xie Y
Cell Biochem Biophys; 2014 Nov; 70(2):1311-6. PubMed ID: 24906237
[TBL] [Abstract][Full Text] [Related]
39. Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma.
Wei K; Li M; Zöller M; Wang M; Mehrabi A; Hoffmann K
Cell Death Dis; 2019 Mar; 10(3):231. PubMed ID: 30850583
[TBL] [Abstract][Full Text] [Related]
40. Scabraside D Derived from Sea Cucumber Induces Apoptosis and Inhibits Metastasis via iNOS and STAT-3 Expression in Human Cholangiocarcinoma Xenografts.
Assawasuparerk K; Rawangchue T; Phonarknguen R
Asian Pac J Cancer Prev; 2016; 17(4):2151-7. PubMed ID: 27221911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
